0.05Open0.05Pre Close0 Volume8 Open Interest50.00Strike Price0.00Turnover0.00%IV99.32%PremiumApr 4, 2025Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma502.20Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Moderna Stock Discussion
Major Breakthrough: Pfizer Teams With Flagship to Develop AI-Driven Autoimmune Treatments
Gapping Up
$Corcept Therapeutics (CORT.US)$ surged over 60% after the company announced that its Phase 3 trial, ROSELLA, met its primary endpoint, improving progression-free survival in platinum-resistant ovarian cancer patients.
$QuantaSing Group (QSG.US)$ surged 20.18% in pre-market trading following a 12% increase on Friday. Last week, QuantaSing Group expanded into the pop toys market through the strategic acqui...
Breakthrough: Moderna Expands Beyond COVID as Australia Approves RSV Vaccine
No comment yet